A Multi-Stakeholder Look at Early Access Pathways

Developing an access program is an intricate process that relies on harmonized efforts from multiple stakeholders.

In this collaborative discussion, industry leaders from across the healthcare spectrum highlight: the roles of different stakeholders in an EAP, communication strategies, real-world data collection (RWD), equitable access to medicine, ethical issues and patient pathways to access.

Let's Connect

For over two decades, Tanner Pharma Group has developed a portfolio of service offerings dedicated improving global access to medicines. Part of our focus is advocating for the rare disease community and offering solutions that can cross borders.

Connect with our team to discover the ways we can increase access to medicine and enable patients, together.

    Our Experience


    20+ years of supporting patient access


    Distribution experience in 150+ countries


    Local resources across 68 countries

    1,000 10,000 100,000 1,000,000

    Patient lives impacted

    Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.